These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19122539)

  • 1. Long-term outcome of anxiety disorders: a review of double-blind studies.
    Thuile J; Even C; Rouillon F
    Curr Opin Psychiatry; 2009 Jan; 22(1):84-9. PubMed ID: 19122539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term management of generalized anxiety disorder: issues and dilemmas.
    Schweizer E; Rickels K
    J Clin Psychiatry; 1996; 57 Suppl 7():9-12; discussion 13-4. PubMed ID: 8690702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment of panic disorder--a critical review of controlled clinical trials.
    Balestrieri M; Ruggeri M; Bellantuono C
    Psychiatr Dev; 1989; 7(4):337-50. PubMed ID: 2577301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of pharmacological and psychological treatments of anxiety.
    Lader MH; Bond AJ
    Br J Psychiatry Suppl; 1998; (34):42-8. PubMed ID: 9829016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan.
    Inada T; Nozaki S; Inagaki A; Furukawa TA
    Hum Psychopharmacol; 2003 Aug; 18(6):483-7. PubMed ID: 12923829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized anxiety disorder. Longitudinal course and pharmacologic treatment.
    Schweizer E
    Psychiatr Clin North Am; 1995 Dec; 18(4):843-57. PubMed ID: 8748384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical course and long-term management of generalized anxiety disorder.
    Rickels K; Schweizer E
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):101S-110S. PubMed ID: 1973934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety symptom severity and functional recovery or relapse.
    Stein DJ; Bandelow B; Dolberg OT; Andersen HF; Baldwin DS
    Ann Clin Psychiatry; 2009; 21(2):81-8. PubMed ID: 19439157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in treatment of anxiety disorders: psychotherapy, pharmacotherapy, and psychosurgery.
    Balon R
    Depress Anxiety; 2004; 19(2):63-76. PubMed ID: 15022141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials.
    Beesdo K; Hartford J; Russell J; Spann M; Ball S; Wittchen HU
    J Anxiety Disord; 2009 Dec; 23(8):1064-71. PubMed ID: 19643572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the therapeutic action of alpidem in anxiety disorders: an overview of the European data.
    Morselli PL
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():129-34. PubMed ID: 1974073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is imipramine or buspirone treatment effective in patients wishing to discontinue long-term benzodiazepine use?
    Sontheimer DL; Ables AZ
    J Fam Pract; 2001 Mar; 50(3):203. PubMed ID: 11252203
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological approaches to the treatment of residual symptoms.
    Fava M
    J Psychopharmacol; 2006 May; 20(3 Suppl):29-34. PubMed ID: 16644769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
    Witte S; Loew D; Gaus W
    Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design.
    Llorca PM; Bodkin JA; Spann M; Ball SG; Russell JM; Ball SG
    J Clin Psychopharmacol; 2009 Feb; 29(1):96-7. PubMed ID: 19142122
    [No Abstract]   [Full Text] [Related]  

  • 17. How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database.
    Baldwin DS; Stein DJ; Dolberg OT; Bandelow B
    Hum Psychopharmacol; 2009 Jun; 24(4):269-75. PubMed ID: 19334042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance treatment studies in anxiety disorders: some methodological notes.
    Rickels K; Schweizer E
    Psychopharmacol Bull; 1995; 31(1):115-23. PubMed ID: 7675975
    [No Abstract]   [Full Text] [Related]  

  • 19. Alprazolam (Xanax, and others) revisited.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):5-7. PubMed ID: 15647704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bromazepam(Lexotan) and chlorprothixene(Taractan) in psychoneurotic anxiety states. A randomized, double-blind study from general practice concerning the effect, drug consumption, and risk of repeated treatment].
    Fynboe C; Christensen N; Halberg T; Hansen EA; Holm P; Knudsen JP; Lindhardt J; Maul B; Musaeus C; Nielsen MT; Schaumburg E
    Ugeskr Laeger; 1981 Oct; 143(41):2641-5. PubMed ID: 6117963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.